Financial statements Rapiomed Group
Balance sheet data of RAPIOMED GROUP
|
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 561,17 | 393,33 | 61 265,05 | 6 139 165,60 | 11 396 419,49 | 14 766 318,26 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 634 987,79 | 493 879,39 | 352 770,99 |
| B. Current assets | 1 561,17 | 393,33 | 61 265,05 | 5 504 177,81 | 10 902 540,10 | 14 413 547,27 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | - | - |
| D. Own shares (stocks) | 0,00 | - | - | - | - | - |
| Total liabilities | 1 561,17 | 393,33 | 61 265,05 | 6 139 165,60 | 11 396 419,49 | 14 766 318,26 |
| A. Equity | 1 189,89 | -4 845,67 | 13 084,56 | 3 262 982,65 | 8 307 754,25 | 11 608 042,80 |
| B. Liabilities and provisions for liabilities | 371,28 | 5 239,00 | 48 180,49 | 2 876 182,95 | 3 088 665,24 | 3 158 275,46 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 371,28 | 5 239,00 | 48 180,49 | 2 876 182,95 | 3 088 665,24 | 3 158 275,46 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.